Mechanisms involved in the generation of spontaneous uterine contractions are not fully understood. Kit-expressing interstitial cells of Cajal are pacemakers of contractile rhythm in other visceral organs, and recent studies describe a role for Ca 2+ -activated Cl À currents as the initiating conductance in these cells. The existence and role of similar specialized pacemaker cells in the nonpregnant uterus remains undetermined. Spontaneous contractility patterns were characterized throughout the estrous cycle in isolated, nonpregnant mouse uteri using spatiotemporal mapping and tension recordings. During proestrus, estrus, and diestrus, contraction origin predominated in the oviduct end of the uterus, suggesting the existence of a dominant pacemaker site. Propagation speed of contractions during estrus and diestrus were significantly slower than in proestrus and metestrus. Five major patterns of activity were predominantly exhibited in particular stages: quiescent (diestrus), high-frequency phasic (proestrus), low-frequency phasic (estrus), multivariant (metestrus), and complex. Kit-immunopositive cells reminiscent of pacemaking ICCs were not consistently observed within the uterus. Niflumic acid (10 lM), anthracene-9-carboxylic acid (0.1-1 mM), and 5-nitro-2-(3-phenylpropylamino)benzoic acid (10 lM) each reduced the frequency of spontaneous contractions, suggesting involvement of Cl À channels in generating spontaneous uterine motor activity. It is unlikely that this conductance is generated by the Ca 2+ -activated Cl À channels, anoctamin-1 and CLCA4, as immunohistochemical labeling did not reveal protein expression within muscle or pacemaker cell networks. In summary, these results suggest that spontaneous uterine contractions may be generated by a Kitnegative pacemaker cell type or uterine myocytes, likely involving the activity of a yet-unidentified Cl À channel.
INTRODUCTION
Spontaneous contractions of the uterus must be strictly controlled and coordinated for the success of various reproductive functions. Through increased contractility, or periods of relative quiescence, the nonpregnant uterus facilitates ova and sperm transport, provides adequate embryo placement for implantation, and contributes to the expulsion of menstrual debris [1] . Uterine dysmotility-where such contractions become insufficient, hyperactive, or asynchronous [2] -has been implicated in the pathogenesis of certain infertilities, implantation failure, endometriosis, dysmenorrhea, and abnormal menstrual events [3] . Although these conditions may not contribute to mortality, they are debilitating clinical disorders that can significantly affect patients' reproductive health, and considerably alter their quality of life [4] [5] [6] . The mechanisms by which the nonpregnant uterus autonomously initiates spontaneous contractions remain speculative and poorly understood, and, despite significant clinical implications, the properties of contractility throughout the estrous cycle have not been thoroughly investigated. Consequently, development of adequate diagnostic techniques and pharmacological treatments for uterine contractility disorders has been impeded, resulting in therapeutic interventions that are largely empirical, symptomatic, and clearly suboptimal.
Early studies have purported that contractility in spontaneously active organs occurs as an intrinsic property of the muscle [7, 8] . More recently, an independent population of cells-interstitial cells of Cajal (ICCs)-have been recognized as pacemakers of contractile rhythm in the gastrointestinal (GI) tract. These cells are distinguished from other GI cell types by expression of Kit, a tyrosine kinase receptor essential for development and maintenance of the ICC phenotype [9] . Much interest has subsequently focused on investigating the existence of similar Kit-positive cells in other autorhythmic smooth muscles. To date, interstitial Cajal-like cells (ICLCs) have been reported in numerous viscera, including the urinary bladder [10] [11] [12] , urethra [13] , prostate [14, 15] , vas deferens [16] , oviduct [17] , and cervix [18] . However, reports describing the presence of ICLCs in the uterus are scarce and have remained controversial.
Debate over uterine Kit immunoreactivity has mostly been attributable to a lack of consistency between examined tissue types, with samples varying in species, preparation, and pregnancy status. For instance, cultured human myometrial cells have been shown to express Kit and exhibit spontaneous electrical potentials reminiscent of classical ICCs [19] . Despite this, use of isolated cells for study of pacemaking activity is questionable, given that proteins and signal transduction pathways crucial for autorhythmicity can be altered by cell culture conditions [20, 21] . Moreover, Hutchings et al. [22] reported Kit-immunopositive structures in human uterus at term, while a further study by Duquette et al. [23] could not detect Kit in pregnant human or rat myometrium acquired from a similar gestational time. Finally, nonpregnant uterine motor activity has been suggested to be functionally dependent on Kit signaling due to the frequency of longitudinal contractions in muscle strips being reduced in mice with alleged geneticallydiminished Kit expression, and by pharmacologically blocking Kit receptor activity [24] . Taken together, examination of ICLC Kit expression in intact, nonpregnant uterine preparations is necessary to address these discrepancies.
In addition to investigating the presence and role of ICLCs in uterine contractility, the ionic currents underlying spontaneous myometrial electrical events is still debated. Preliminary studies suggested that pacemaking oscillations in rhythmically active, ICC-driven visceral organs (including those of the GI tract) involved nonselective cation currents [25] [26] [27] . However, more recently, a consensus has formed that Ca 2þ -activated Cl À channels (CaCCs) provide the primary depolarizing conductance underlying rhythmicity in these organs. Hirst et al. [28] presented pharmacological evidence that CaCCs were fundamentally important in the generation of ICC-mediated pacemaking activity in gastric tissues. The observations that spontaneous depolarizations in GI ICCs were blocked by niflumic acid (NFA) (a potent Cl À channel antagonist), have reversal potentials consistent with Cl À currents, and display unitary conductances similar to anoctamin-1 (Ano1) CaCCs have all added strength to this hypothesis [29] . In agreement with these findings, ICCs and Ano1 are immunohistochemically coexpressed in GI tissues, and spontaneous GI motility fails to develop in Ano1 knockout mice [30, 31] . Interestingly, CaCCs have also been implicated in the generation of spontaneous pacemaker depolarizations in urethral, lymphatic, and oviduct smooth muscle [17, 32, 33] . Two independent research groups have documented CaCCs in the rat myometrium [34, 35] , one of which was cloned and named ''CLCA4.'' Myometrial CaCCs had electrophysiological characteristics directly comparable to GI Ano1, and produced inward currents in a subpopulation of cells [34] . Nonetheless, it remains unclear whether CaCCs are specifically expressed in specialized pacemaker cell networks and are fundamental to the generation of spontaneous uterine contractions.
The aims of this study were three-fold: 1) to fully characterize the contractility patterns of the mouse uterine horn and investigate how these change during the estrous cycle; 2) to examine the hypothesis that Kit-positive interstitial cells are present within the spontaneously active nonpregnant uterus; and 3) to determine whether CaCCs are the molecular correlate of the rhythmic depolarizing currents that underlie spontaneous uterine contractility.
MATERIALS AND METHODS

Animals
Cytological evaluation of vaginal smears from 6-to 12-wk-old, virgin, female C57BL/6 mice was used to determine their current stage of estrous. Briefly, mice were gently restrained, and their vaginas flushed one to two times with 20 ll PBS (0.01 M; pH 7.4). Care was taken not to insert the pipette more than 2 mm into the vaginal orifice. The resultant unstained cellular solution was viewed on standard microscope slides using bright-field lighting, and estrous stage classified based on previously described criteria [36] (Fig. 1 ). Animals were anesthetized by isoflurane inhalation and culled by cervical dislocation prior to removal of the uterus and small intestine. Animals were obtained from the University of Adelaide Laboratory Animal Services; all experimental procedures were performed in accordance with the University of Adelaide Animal Ethics Guidelines, and approved by the University of Adelaide Animal Ethics Committee.
Spatiotemporal Mapping
Isolated uteri were submerged into an organ bath filled with warmed (36 6 18C) oxygenated Krebs solution (approximate volume, 55 ml), and secured to the Sylgard-coated base (Dow Corning) at each oviduct and the uterine body using entomology pins. After approximately a 30-min equilibration, preparations were illuminated from beneath and spontaneous diameter changes over time recorded using an inverted digital video camera (Computar M0814-MP). Spatiotemporal diameter maps were constructed from individual video recordings using the Gastrointestinal Motility Monitoring system (MedAssociates). In brief, uterus images in each video frame were converted to silhouette, and changes in luminal diameter at each point along the length of the horns translated into grayscale pixels. Instances of minimal uterine diameter (contraction/constriction) were represented on maps as regions of white, 
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whereas maximal diameter (relaxation/distension) as regions of black. Calibration bars for each map show changes of diameter as grayscale (mm), time (s), and length of uterine horn sampled (mm), from which contraction origin and propagation speed (mm Á s À1 ) for each estrous stage was determined.
Mechanical Recordings
Three high-sensitivity tension transducers (AD Instruments MLT0202) were attached in the circumferential direction via a hook and silk suture thread at the oviduct, mid-and body regions of the right uterine horn. Curved entomology pins were positioned over the preparation in between the hooks to further secure the uterus to the base of the organ bath. Tissues were then placed under a basal tension of 10 6 2 mN and left to equilibrate for approximately 1 h. Analog signals recorded via isometric tension transducers were amplified by a quad bridge amp (AD Instruments ML224) before being converted to digital signals using a Powerlab 4/35 data acquisition device (AD Instruments) and recorded for later analysis on a PC running LabChart 7 software (AD Instruments).
A second cohort of uteri from the estrus stage of the estrous cycle were mounted in a two-chambered organ bath, with a partition separating the oviduct end from the mid-and body regions of the right uterine horn (Fig. 2) . The partition contained a pore comprised of thin latex rubber fixed between two plastic sheets, through which the uterine horn was passed and sealed watertight with high-vacuum silicone grease (Dow Corning). The separation of perfusates in each chamber was validated by observing no interchamber leakage when blue food dye was added to a single compartment (Supplemental Fig. S1 ; Supplemental Data are available online at www.biolreprod.org). Tension transducers were attached as described above. In separate experiments, the Cl À channel antagonists NFA (10 lM), anthracene-9-carboxylic acid (9-AC; 100 lM and 1 mM) and 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB; 10 lM) were either added to the oviduct division alone (partitioned) or to all regions of the horn (nonpartitioned) for at least 30 min, and changes in tension parameters for each region were analyzed. This comprised contraction amplitude (mN), frequency (contractions per min [cpm]), and half-maximal duration (s).
Immunohistochemistry
For whole-mount preparations, uterine horns and small intestine segments were opened along their respective mesometrial and mesenteric borders, and firmly pinned to the base of a Sylgard-coated dish containing PBS (0.01 M). Endometrial and mucosal layers were removed by sharp dissection, and the remaining tissues fixed in paraformaldehyde (4% in 0.01 M PBS; pH 7.2; 10 min). After rinsing (3 3 20-min washes) in PBS, tissues were incubated in bovine serum albumin (BSA; 1% in 0.01 M PBS at room temperature [RT]; 1 h) to reduce nonspecific antibody binding. Each preparation was then incubated at 48C with primary antibodies in Triton X-100 (0.3% in 0.01 M PBS; 48 h) either individually or in the following combinations: smooth muscle actin (SMA) and Kit; SMA and Ano1; SMA and CLCA4; CLCA4 and neurofilament 200 (NF200); and CLCA4 and calcitonin gene-related peptide (CGRP). Immunoreactivity was detected by using appropriate Alexa Fluor-conjugated secondary antibodies (RT in 0.01 M PBS; 1 h), rinsed (3 3 20-min washes) between all incubations. For NF200 labeling only, tissues were additionally blocked (RT; 2 h) using donkey anti-mouse AffiniPure Fab fragment (0.1 mg/ ml; Jackson ImmunoResearch) prior to primary antibody incubation. Antibody details and concentrations are shown in Table 1 .
For cryostat sections, intact uterus and small intestinal segments were fixed in paraformaldehyde (4% in 0.01 M PBS; pH 7.2; 10 min). After rinsing (3 3 20-min washes), tissues were placed in sucrose solution at 48C (30% in 0.01 M PBS; overnight) for cryoprotection. Each preparation was then placed in optimal temperature cutting compound (Tissue-Tek; at RT for 1 h) before being rapidly frozen in isopentane cooled by liquid nitrogen. Cryostat sections (10 lm) were cut serially using a cryostat (Leica CM3050) and collected onto standard glass microscope slides. Tissues sections were allowed to air dry at RT for 1 h, rinsed (0.01 M PBS; 10 min), and incubated in BSA (1% in 0.01 M PBS at RT; 1 h). Sections were then sequentially incubated under humid conditions in primary (48C; overnight) and conjugated secondary antibodies (RT; 1 h) in a manner similar to that described for whole mounts.
Control samples were prepared by omitting either primary or secondary antibodies from the incubation solution. Tissues were examined and images captured using a Leica SP5 laser scanning confocal microscope with FIG. 2. Tissue preparation and experimental setup utilized in mechanical tension recording studies. For each mechanical experiment, the right uterine horn was isolated and mounted in an organ bath. For partition bath experiments, in which drugs could be restricted to the oviduct end of the uterine horn, a partition was mounted approximately 10 mm from the ovary. Small metal rakes and suture threads were used to relay tension changes generated in the wall of the uterine horn to three independently mounted high-sensitivity tension transducers. 
Solutions and Drugs
All bath chambers were constantly perfused with oxygenated Krebs solution of the following composition: 118.0 mM NaCl; 4.75 mM KCl; 25.0 mM NaHCO 3 ; 11.0 mM glucose; 1.2 mM MgSO 4 ; 1.0 mM NaH 2 PO 4 ; 2.5 mM CaCl 2 , collectively dissolved in deionized water. Krebs pH was 7.3-7.4 when bubbled with 95% O 2 /5% CO 2 at 36 6 18C. PBS (0.01 M) was diluted from 103-concentrated stock containing: 137.0 mM NaCl; 2.7 mM KCl; 1.5 mM KH 2 PO 4 ; 8.0 mM Na 2 HPO 4 (anhydrous), collectively dissolved in deionized water. NFA, 9-AC, and NPPB (Sigma) were dissolved in absolute ethanol or dimethyl sulfoxide to make stock concentrations before being diluted in the perfusion solution at the working concentrations stated previously. Final concentrations of the solvents in the perfusate did not exceed 0.1%.
Data Analysis
Data are expressed as means 6 SEM, and the 'n' values in the text refer to the number of animals used for each experimental protocol. GraphPad Prism 6 for Windows (GraphPad Software Inc.) was used to perform statistical analysis. Comparisons of contractility parameters at each stage of the estrous cycle were analyzed using one-way ANOVA with Tukey post hoc analysis. Differences in data following application of Cl À channel blockers were determined by paired ttests with Wilcoxon matched-pairs signed rank post hoc correction. Statistical significance was accepted for P values , 0.05.
RESULTS
Characterization of Spontaneous Contractility Throughout the Estrous Cycle
Spatiotemporal mapping revealed distinct patterns of spontaneous uterine circular muscle contractions at each stage of the estrous cycle. It was confirmed that the contractile patterns observed via spatiotemporal mapping were not neurally mediated, as application of the neural (fast sodium channel) blocker tetrodotoxin (1 lM) to the perfusate did not alter mechanical activity (n ¼ 8; data not shown). Proestrus often displayed pulse-like contractions at the oviduct end of the uterine horn that occasionally disseminated right through to the body end (Fig. 3, A and B) . Large contractions, which originated at the oviduct end of the horn and propagated to the body region in a squeezing-type motion, were commonly observed in estrus (Fig. 3, C and D) . Metestrus contractions typically conducted at a higher velocity than other stages, and initiated in similar proportions from both the oviduct and body regions of the uterine horn, often colliding around the mid region (Fig. 3, E and F) . Diestrus tended to show relatively long periods of quiescence that were interrupted by sporadic, small-amplitude bursts of contractions with no apparent polarized origin (Fig. 3, G and H) .
Propagation speeds of the spontaneous contractions were similar between proestrus and metestrus, averaging 1.3 6 0.1 and 1.2 6 0.1 mm Á s À1 , respectively. Contractions during estrus (0.9 6 0.1 mm Á s À1 ) and diestrus (0.7 6 0.1 mm Á s
À1
), however, propagated significantly slower (P , 0.01 compared to proestrus and metestrus; n ¼ 8 per stage; Fig. 3I ). Contraction origin proportionately dominated from the oviduct end in proestrus and estrus (86.7 6 8.8 and 86.0 6 6.1%, respectively), while contractions derived from the uterine body end averaged 5.9 6 5.8 and 5.2 6 2.8%, respectively. In contrast, significantly fewer contractions originated from the oviduct in metestrus (42.6 6 9.6%), and more initiated from the body end of the horn (38.3 6 11.2%). In diestrus, 59.5 6 11.9% of spontaneous contractions originated from the oviduct end and 30.2 6 10.3% from the uterine body, although these proportions did not significantly differ from all other stages (n ¼ 8 per stage; Fig. 3J ).
Mechanical tension recordings obtained from the uterine horns were remarkably variable, both between stages of the estrous cycle and in different regions of tissue. Mechanical activity from the three recording sites (n ¼ 40; 10 animals per estrous stage) was therefore classified into one of five categories according to criteria based on amplitude, frequency, and half-maximal duration. Recordings with no visible events over a 30-min period were considered quiescent (n ¼ 4; Fig. 4A ). High-frequency (HF) phasic contractions were characterized by !3 cpm (average. 4.0 6 0.3 cpm), and were typically of small amplitude (,5 mN; average. 4.2 6 0.2 mN) (n ¼ 13; Fig. 4B ). Low-frequency (LF) phasic contractions had lower frequencies (,3 cpm; average. 1.2 6 0.4 cpm), and often displayed larger amplitudes (.5 mN; average, 9.8 6 0.2 mN) (n ¼ 27; Fig. 4C ). Multivariant activity contained both small and large amplitude contractions, small amplitude (average, 2.3 6 0.1 mN) being defined as contractions with amplitudes ,40% of the mean maximum contractions (average, 6.9 6 0.2 mN) (n ¼ 11; Fig. 4D ). Finally, complex contractions occurred at very low frequencies (,0.2 cpm; average, 0.06 6 0.02 cpm), exhibited half-maximal durations that exceeded 100 sec (average, 215.4 6 25.0 sec), and had !10 superimposed peaks (average, 17 6 0.8 peaks) (n ¼ 5; Fig. 4E ).
While all stages produced large phasic contractions, each also exhibited a large proportion of a distinguishing activity type. Proestrus displayed 36.0 6 3.6% HF phasic contractions; estrus produced the majority (83.3 6 8.8%) of LF phasic contractions; and metestrus generated 43.3 6 6.6% multivariant activity (n ¼ 10 per stage; Fig. 5 , A-C). Diestrus did not display an obviously predominant type of activity, although notably produced the greatest proportion (13.3 6 8.8%) of quiescence (n ¼ 10; Fig. 5D ; summarized in Fig. 5E ).
Kit Expression in the Myometrium
To examine the presence of Kit-expressing ICLCs in the uterus, Kit immunohistochemistry was performed. In wholemount preparations of uterus, Kit immunoreactivity was not detected (n ¼ 10; Fig. 6A ). Double labeling with antibodies to SMA and Kit in cryostat sections of intact uterus also failed to reveal Kit-immunopositive structures (Fig. 6B) . The only exception to this was a single, spindle-shaped, Kit-expressing structure observed within the muscle layer in one preparation (Fig. 6C) . In segments of small intestine, used as a positive control tissue, Kit immunohistochemistry revealed a population of cells with oval-shaped cell bodies and multiple processes, which formed clear anastomosing networks throughout the myenteric plexus (n ¼ 10; Fig. 6, D and E) . These cells were morphologically consistent with classical pacemaker myenteric interstitial cells of Cajal (ICC-MY), as described by others [37] [38] [39] .
Effects of Cl À Channel Blockers on Spontaneous Uterine Contractility
The effect of three Cl À channel blockers, NFA (10 lM), NPPB (10 lM), and 9-AC (100 lM and 1 mM), were examined on contractile activity of uterine horns isolated at estrus. This stage of the estrous cycle was selected for these studies as it exhibited the least degree of variability between individual animals and was mostly characterized by LF phasic contractions, simplifying the analysis of drug effect. For partitioned experiments, the oviduct end was chosen to receive the drug treatments, as this region was determined by the preceding studies to be the dominant pacemaker site for DODDS ET AL. 
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À CHANNEL BLOCKADE uteri in estrus. To provide assurance that changes in contractile parameters were due to the action of Cl À channel blockade, and not simply attributed to an inherent decline of mechanical activity, a series of time-control experiments were also performed (n ¼ 6). Time-control experiments demonstrated that frequency, amplitude, and half-maximal duration of uterine contractions did not change significantly by the end of the 30-min period that paralleled the duration of drug incubation (data not shown). Changes in uterine contractile parameters in response to Cl À channel blockers and associated P values are provided in Supplemental Table S1 (partitioned organ bath) and Supplemental Table S2 (nonpartitioned organ bath).
Niflumic acid. In two of seven uterus preparations, restricted application of NFA (10 lM) to the oviduct end of the uterine horn abolished contractions in this region. In the remaining five preparations, contraction frequency within the ovi region was approximately 60% of predrug values (1.4 6 0.2 to 0.4 6 0.1 cpm; Fig. 7, A and B) . Average contraction frequency in the mid region was 1.2 6 0.1 cpm prior to, and 0.5 6 0.1 cpm following, NFA application to the ovi end (Fig. 7, C and D) , and contraction frequency at the body end was reduced from 1.1 6 0.2 to 0.4 6 0.1 cpm (n ¼ 7; Fig. 7 , E and F). With the exception of the blockade of activity in the oviduct end of two preparations, contraction amplitude was unaffected in all regions, and duration was only altered in the body end of the horn, increasing from 6.4 6 0.8 to 8.3 6 0.8 sec.
In nonpartitioned experiments, bath application of NFA (10 lM) to the entire uterine horn significantly reduced the frequency of spontaneous contractions in all three regions compared with predrug conditions (ovi, Fig. 7 , G-L). Activity was abolished across the uterine horn in one preparation, and additionally in the oviduct end of a second preparation. Contraction amplitude was unaffected in the oviduct and mid regions, although it was significantly attenuated in the uterine body (8.9 6 1.4 to 4.8 6 1.5 mN). Half-maximal duration of contractions remained unchanged at all sites.
5-nitro-2-(3-phenylpropylamino)benzoic acid. NPPB (10 lM) added exclusively to the oviduct end of the horn did not abolish activity, although it reduced contraction frequency in all uterine regions (ovi, 1.5 6 0.2 to 0.8 6 0.2 cpm; mid, 1.2 6 0.2 to 0.8 6 0.1 cpm; body, 1.2 6 0.2 to 0.8 6 0.1 cpm; n ¼ 7; Fig. 8, A-F) . Contraction amplitude did not change following NPPB administration, and duration was only decreased in the oviduct end from 7.5 6 0.6 to 5.2 6 0.7 sec.
Application of NPPB (10 lM) to the entire uterine horn in nonpartitioned bath experiments decreased contraction frequency in all regions (ovi, 1.4 6 0.2 to 0.9 6 0.1 cpm; mid, 1.5 6 0.2 to 0.9 6 0.2; body, 1.4 6 0.2 to 0.8 6 0.2; n ¼ 6; Fig. 8 , G-L). However, spontaneous activity did not completely cease in any preparation. Contraction amplitude in the oviduct end was decreased (8.0 6 0.7 to 6.4 6 0.9 mN), although it was unaffected in the mid and the body. Furthermore, contraction duration remained similar to predrug values.
Anthracene-9-carboxylic acid. A lower concentration of 9-AC (100 lM) applied exclusively to the oviduct end of the uterine horn did not significantly alter any contractile parameters measured within any region of the uterine horn (n ¼ 7). However, when added to the whole bath, contraction frequency was attenuated in the oviduct end from 1.4 6 0.1 to 1.2 6 0.1 cpm and in the mid region from 1.4 6 0.1 to 1.3 6 0.1 cpm, while frequency at the body was unchanged (n ¼ 10). Activity was not completely blocked by this concentration of 9-AC in any region. Interestingly, contraction amplitude was significantly enhanced in the ovi and mid regions by 100 lM 9-AC (7.1 6 0.7 to 8.1 6 0.9 mN and 7.2 6 0.6 to 9.0 6 0.7 mN, respectively). The half-maximal duration of contractions was again unaltered by this drug in all regions.
At a higher concentration of 1 mM, 9-AC applied to the oviduct-end bath compartment reduced frequency (1.9 6 0.2 to 1.4 6 0.2 cpm) and increased the duration of contractions (6.2 6 0.7 to 9.2 6 0.8 sec) at this site and also in the mid uterus (1.8 6 0.2 to 1.3 6 0.2 cpm; 6.3 6 1.0 to 7.9 6 1.3 sec), although the uterine body was unaffected for both parameters (Fig. 9, A-F) . In all regions, contraction amplitude was also significantly enhanced (ovi, 9.2 6 1.7 to 10.8 6 1.7 mN; mid, 8.6 6 1.6 to 11.6 6 1.3 mN, body: 7.1 6 1.8 to 9.7 6 2.6 mN).
Contraction frequency was significantly decreased in all regions of the uterine horn when 1 mM 9-AC was perfused into the nonpartitioned bath (ovi, 1.1 6 0.1 to 0.6 6 0.1 cpm; mid, 1.1 6 0.1 to 0.7 6 0.1 cpm; body, 1.1 6 0.1 to 0.7 6 0.1 cpm; n ¼ 10; Fig. 9 , G-L). In one experiment, contractions in the body end were abolished. On average, contraction amplitude was unaffected, whilst contraction duration was significantly increased across at all sites (ovi, 9.4 6 0.5 to 11.2 6 0.4 sec; mid, 8.7 6 0.4 to 11.1 6 0.5 sec; body, 9.2 6 0.7 to 11.0 6 0.9 sec).
CaCC Expression in the Myometrium
Ano1 was not detected in the bulk of the uterine musculature in whole-mount preparations (n ¼ 6; Fig. 10A ),
FIG. 4. Types of spontaneous contractile events exhibited by the isolated uterine horn throughout the estrous cycle. Mechanical activities recorded via high-sensitivity tension transducers were characterized into five distinct types: quiescent (A); HF phasic (B); LF phasic (C); multivariant (D); and complex (E).
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although strong immunoreactivity was detected along the perimetrial surface in cryostat sections (n ¼ 6; Fig. 10B ). Immunohistochemical labeling for Ano1 was performed on preparations of small intestine to provide a positive control for antigen-antibody specificity. Ano1-immunopositive cells in the muscular layers of the small intestine were characteristic of Kitexpressing ICCs: highly branched structures forming dense, highly organized networks in the region of the myenteric plexus (n ¼ 6; Fig. 10C ). In cryostat sections of intestine, Ano1 immunoreactivity was prominent in two regions: interposed between circular and longitudinal muscle layers (in a similar plane to the myenteric plexus), and on the serosal surface (n ¼ 6; Fig. 10D ).
CLCA4 immunoreactivity was sparsely distributed within the myometrial layer; in some cases, arranged reminiscent of blood vessels, and in others, as axon-like structures (Fig. 10, E  and F; Supplemental Fig. S2 ). Putative CLCA4-positive nerves were closely associated, but not colocalized, with adjacent CGRP-positive processes (Supplemental Fig. S2, A-C) . Colocalization between CLCA4 and the neural marker NF200 was observed (Supplemental Fig. S2, D-F) . Segments of small intestine were labeled with antibodies to CLCA4 to serve as a positive control. Here, CLCA4 immunoreactivity was observed in large, ovoid nerve cell bodies located within myenteric ganglia, and intensely labeled multiple processes within interganglionic tracts (n ¼ 6; Fig. 10, G and H) . These structures were determined to coexpress NF200, but, unlike the FIG. 5. Summary of activity types observed in oviduct, mid, and body regions of the isolated uterine horn at different stages of the estrous cycle. HF and LF phasic contractions were the predominant activities recorded at proestrus (A). LF phasic activity was the most prevalent activity seen during estrus (B). At metestrus, a higher proportion of multivariant type of activity was observed (C). Diestrus displayed the greatest proportion of quiescence (D). Percentages of each activity type observed throughout the estrous stages are summarized in E. Bars not sharing the same letter annotations are statistically different (P , 0.05; means 6 SEM; n ¼ 10 per group).
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DISCUSSION
Distinct Patterns of Uterine Contractility Throughout the Estrous Cycle
In this study, we have thoroughly and systematically characterized the mechanical activity of the mouse uterine horn throughout the various stages of the estrous cycle (see . Spontaneous contractility of the cycling nonpregnant uterus has also been studied in the rat [40] [41] [42] [43] , guinea pig [44] , dog [45] , cow [46] [47] [48] [49] , and horse [50, 51] . We have revealed that, despite considerable variability in contractile behaviors, there are certain motility patterns that are more prevalent at each phase of the cycle; changes that likely correspond to the cyclic variation in the levels and receptor expression of ovarian steroid hormones, estrogen and progesterone, which have been shown to modulate spontaneous contractility in vitro [52] [53] [54] [55] [56] and in vivo [41] [42] [43] 57] . Contractions were predominantly initiated from the oviduct end, suggesting that this was the dominant pacemaking site, as has been reported by others [41] . However, it was also found, using partitioned bath experiments, that contractions in the mid and body regions persisted following blockade of activity at the oviduct end of the horn; demonstrating that spontaneous activity can be generated in the mid and body segments of the horn, independently of the oviduct end. Proestrus, the phase of follicular development, showed mostly subtle contractions localized to the oviduct end of the horns. At estrous, contractions were slower, stronger events, which we could presume serves the functional role of propelling a released ovum toward the uterine horn. In metestrus, activity became erratic, propagating toward both the oviduct and the uterine body, an activity pattern that potentially, in vivo, assists with the implantation of fertilized oocytes in the uterine wall. Any unfertilized eggs and endometrial debris are typically accumulated in diestrus, and the short contractile bursts described here at this stage of the cycle may aid in the movement of this debris along the duct.
Despite clear differences in gross anatomy, several parallels can be drawn between our studies on the mouse uterus and those of other mammalian species, including the human. For example, Bulletti et al. [58] observed that the frequency and amplitude of nonpregnant uterine contractions, measured in vivo by transvaginal ultrasound and intrauterine pressure, were at their lowest between the late secretory to early proliferative phase of the human menstrual cycle, similar to the relatively high proportion of quiescent activity that we recorded in diestrus. Although contractions mostly propagated in a retrograde direction (cervix to fundus) across the cycle, this progressively decreased throughout the progesterone-dominant luteal phase when convergent contractions (simultaneous from cervix and fundus) peaked. This is comparable to our reports of activity in metestrus, and was also suggested to favor embryo positioning and implantation. Moreover, Cibils [59] described various patterns of uterine contractility across the menstrual cycle in women via intrauterine catheter: the proliferative phase, consisting predominantly of either HF or LF contractions with moderate to high intensity (analogous to our LF phasic and HF phasic activity), and the secretory phase, characterized by slow, fluctuating contractions with superimposed small, fast, frequent contractions (similar to our complex activity), or by relative quiescence.
Therefore, our comprehensive recordings using spatiotemporal mapping and tension measurements can provide a suitable in vitro animal alternative for future studies investigating uterine physiology, as well as potential pharmacological treatment options for associated dysmotility diseases. Future studies should now focus on determining the molecular signaling pathways that confer these changes in contractility, and how alterations may lead to pathology. 
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Lack of Kit-Like Immunopositive Structures in the Nonpregnant Mouse Myometrium
In response to the considerable inconsistency in the literature regarding the existence of putative 'ICC' pacemaker cells in the myometrium, we have examined the nonpregnant uterus for the expression of Kit-the classical hallmark protein of interstitial cells in the GI tract and other visceral organs (see Fig. 6 ). From our immunohistochemical investigation, we found little evidence for the presence of Kit-positive cells in the bulk musculature of the myometrium. We did identify a single Kit-positive structure, which bore some resemblance to other reports describing ICLC Kit expression in the uterus [19, 22, 24] . It is unlikely that this was a mast cell, also known to express Kit [60] , as these cells are typically round and found in abundance. The Kit-immunopositive structure observed was inconsistent with ICC-like Kitimmunoreactivity in the small intestine in that it did not form part of an anastomosing network. Similar disparate, spindle-shaped, Kit-immunopositive structures have been reported in the cervix, but not in the vagina of the mouse [18] . Our observations lead us to preclude Kit-expressing ICLCs as the cell type responsible for generating spontaneous uterine contractility in the nonpregnant mouse uterus. (A and B) , mid (C and D), and body regions (E and F) of the uterus for partitioned preparations, and ovi (G and H), mid (I and J), and body regions (K and L) for nonpartitioned preparations. Scale bars in E (10 min and 5 mN) also apply to A and C (unless otherwise noted); scale bars in K (10 min and 5 mN) also apply to G and I. Dotted lines denote duration and location of NFA in bath. Black circles in summarized data show values recorded from control conditions, and white circles represent those in the presence of NFA. Data are expressed as means 6 SEM. *Significant change (P , 0.05; n ¼ 7 for partitioned and n ¼ 6 for nonpartitioned bath experiments).
UTERINE CONTRACTIONS AND CL
À CHANNEL BLOCKADE Controversially, it has been suggested that spontaneous uterine contractions are dependent upon Kit-positive interstitial cells in the mouse, based on the observation that longitudinal muscle contractions from the uterus of KitW v /KitW v mice occur at a lower frequency than wild-type or heterozygous animals [24] . These findings contrast with the present study, in which Kit-immunopositive structures were not consistently observed. Given that Allix et al. [24] propose that Kit-expressing cells are critical for uterine contractility, it remains unclear why the presumed loss of Kit expression in KitW v /KitW v mice would have no apparent influence on circular muscle activity or the amplitude of longitudinal contractions. The subtle changes of uterine longitudinal muscle contraction frequency reported by this group are in contrast to the substantial changes in both electrical and mechanical activity exhibited by gastrointestinal muscle devoid of Kit-positive ICC [37, 39, 61] .
The scarcity of Kit-immunopositive structures in the mouse uterus in this and other studies does not eliminate the possibility that a specialized uterine pacemaker cell type exists. Not all pacemaker activity is critically dependent on Kitimmunoreactive cells; spontaneous electrical activity in the urethra has been described in vimentin-positive ICLCs that are (A and B) , mid (C and D), and body regions (E and F) of the uterus for partitioned preparations, and ovi (G and H), mid (I and J), and body regions (K and L) for nonpartitioned preparations. Scale bars in E (10 min and 5 mN) also apply to A and C (unless otherwise noted); scale bars in K (10 min and 5 mN) also apply to G and I. Dotted lines denote duration and location of NPPB in bath. Black circles in summarized data show values recorded from control conditions, and white circles represent those in the presence of NPPB. Data are expressed as means 6 SEM. *Significant change (P , 0.05; n ¼ 7 for partitioned and n ¼ 6 for nonpartitioned bath experiments).
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Kit negative [13] . Vimentin-positive ICLCs have also been described in dispersed cells and intact tissues isolated from the pregnant rat and human uterus [23] . However, interestingly, a role for vimentin-positive ICLCs as excitatory pacemakers within the myometrium was not supported, as, unlike isolated myometrial smooth muscle cells from the same preparations, they failed to exhibit spontaneous inward currents under voltage clamp [23] . An interesting direction for subsequent investigation would be to determine if spontaneous depolarizing currents are exhibited by vimentin-positive ICLCs of the more mechanically active nonpregnant uterus. Several studies have also suggested that certain smooth muscle populations in the portal vein [62] and ureter [63] are intrinsically capable of generating spontaneous activity. It remains possible that the spontaneous rhythmicity of the uterus is due to an intrinsic property of the uterine myocytes themselves, or a subpopulation of atypical myocytes.
Cl
À Conductances and Uterine Pacemaker Events
Cl À channels have been classically linked to the generation of contractile tone and spontaneous contractility in many   FIG. 9 . Changes in contraction frequency elicited by application of 9-AC (1 mM). Representative traces of mechanical activity and summarized data of frequency changes in the ovi (A and B), mid (C and D), and body regions (E and F) of the uterus for partitioned preparations, and ovi (G and H), mid (I and J), and body regions (K and L) for nonpartitioned preparations. Scale bars in E (10 min and 5 mN) also apply to A and C; scale bars in K (10 min and 5 mN) also apply to G and I. Dotted lines denote duration and location of 9-AC in bath. Black circles in summarized data show values recorded from control conditions, and white circles represent those in the presence of 9-AC. Data are expressed as means 6 SEM. *Significant change (P , 0.05; n ¼ 7 for partitioned and n ¼ 10 for nonpartitioned bath experiments).
UTERINE CONTRACTIONS AND CL
À CHANNEL BLOCKADE smooth muscle organs [64] [65] [66] , and recent studies have implicated their importance as the underlying 'pacemaker conductance' in the uterus [34, 35] . In the current study, Cl À channel blockade by NFA, NPPB, and 9-AC reduced the frequency of spontaneous uterine contractions, suggesting that a Cl À conductance is fundamentally important in the generation of spontaneous rhythmicity in the uterus (see Figs. 7-9) .
CaCCs have been implicated as the generators of pacemaker activity in other visceral organs, including the GI tract, for a number of years [28, 67, 68] . Recently, strong genetic and pharmacological evidence has accumulated that CaCCs encoded by Tmem16a are expressed by ICC, and are responsible for coupling an elevation in intracellular Ca 2þ to membrane depolarization [69] . In addition to their important role in the generation of slow wave activity, CaCCs are thought to be responsible for producing depolarizing responses to enteric excitatory neurotransmitters [29, 69, 70] .
In the urethra, CaCCs within ICCs have also been reported, where they generate large-amplitude spontaneous Cl À currents and are proposed to serve as 'pacemakers' of slow wave activity [71, 72] . In support of this, CaCC inhibitors, such as 9-AC and NFA, have been shown to pharmacologically block spontaneous 'pacemaker' oscillations in urethral ICCs [71] .
Most Cl À channel blockers are known to have various nonspecific effects; in particular, NFA can stimulate intracellular Ca 2þ release [73, 74] , and block nonselective cation [75] , L-type Ca 2þ [76] , and Ca 2þ -activated K þ channels [77] . Therefore, we need to consider the possibility that the inhibitory effects observed may be attributable to these phenomena, rather than their Cl À channel-blocking abilities. It is unlikely, however, that these drugs are nonselective in the same way, and since they exerted similar effects on contraction frequency, this adds strength to the hypothesis that Cl À channels contribute to the generation of contractile events within the uterus. Interestingly, while NFA, NPPB, and the low concentration of 9-AC (100 lM) either had no effect upon or decreased the amplitude of myometrial contractions, the higher concentration of 9-AC (1 mM) was found to increase contraction amplitude. Similar effects of 9-AC on myometrial contraction amplitude and frequency have been reported in the pregnant rat myometrium [78] , although others report a 9-ACinduced suppression of both contraction amplitude and frequency [79] . The reason for the inconsistent effects of 9-AC on uterine contraction amplitude remains unclear, but may relate, in part, to the variation in species and pregnancy status in individual studies. Nevertheless, our observation, that the higher concentration of 9-AC induced an increase in contraction amplitude and duration, provides assurance that this agent is unlikely to reduce contractility via a nonspecific inhibition of Ca 2þ entry through voltage-dependent Ca 2þ channels.
CaCC Expression in the Myometrium
Ano1. The CaCC, Ano1, genetically encoded by Tmem16a, has been identified as the molecular correlate of the pacemaking conductance in the GI tract [31, 69] . Ano1 expression has also been reported in the urethra of mice, rats, and sheep; although, here, it was detected on smooth muscle and urothelial cells, but not on vimentin-positive ICCs [80] . Cl À entry through Ano1 channels appears critical for generation of slow waves and corresponding contractile activity of the oviduct, as, unlike their wild-type littermates, neonatal mice homozygous for a null allele of Tmem16a lack electrical slow-wave activity in the myosalpinx [17] .
In the present study, Ano1 could not be detected by immunohistochemistry in the bulk musculature of the myometrium, suggesting that, unlike the oviduct, Ano1 is not the molecular candidate for the CaCC involved in spontaneous uterine contractility (see Fig. 10 ). The lack of Ano1-like immunoreactivity in our study is unlikely to be due to issues FIG. 10 . Distribution of CaCCs Ano1 and CLCA4 in the uterus and small intestine. Ano1 immunoreactivity (red) could not be detected within uterine smooth muscle (SMA; green) in whole-mount preparations (A), but was expressed on the perimetrium in cryostat sections (arrowhead; B). ICC identified by Ano1 immunoreactivity in the small intestine (C). Crosssection through intestinal wall showing location of Ano1 between smooth muscle (arrow; D) and on the serosa (arrowhead; D). CLCA4-positive structures (red) within blood vessels (arrowheads) and also dispersed within the bulk myometrium (arrows) labeled with antibodies to SMA (green; E and F). CLCA4 expression in the region of the myenteric plexus of the small intestine (arrow) (G and H). Bar in H ¼ 25 lm and applies to all images (n ¼ 6).
with antibody-antigen binding, as robust Ano1 immunoreactivity was detected within intestinal tissues and also on the perimetrial surface of the uterus. On the outer serous coat of the uterus, Ano1 channels are likely to serve a secretory role, as has been suggested for airway epithelia, the intestine, kidneys, pancreas, and salivary glands [81] [82] [83] [84] .
CLCA4. Ca 2þ -activated Cl À conductances (I Cl-Ca ) recorded from isolated cells of the myometrium have similar electrophysiological characteristics to GI Ano1, and have been shown to contribute to both spontaneous and oxytocin-stimulated contractions [34, 35] . Interestingly, an I Cl-Ca was found in only 30% of isolated myometrial cells [34] , suggesting CaCC channel expression within a specific population of uterine cells. Song et al. [35] cloned and functionally analyzed CLCA4, and, based on the temporal expression profile (with higher expression immediately prior to and following parturition) and the electrophysiological characteristics of I Cl-Ca , CLCA4 was put forward as a potentially important regulator of myometrial contractility. These previous findings, and the report of CLCA4 transcripts with mouse uterus [85] , provided the rationale for the examination of CLCA4 distribution in the current study.
CLCA4 immunohistochemistry in the nonpregnant uterus did not, however, reveal a subpopulation of CLCA4-expressing myocytes or other structures consistent with a typical pacemaking cell network (see Fig. 10 ). CLCA4 was detected in a subpopulation of NF200-positive nerve terminals in both uterus and small intestine. Double labeling with the sensory nerve marker CGRP revealed that, while a subpopulation of intestinal CLCA4-positive structures also coexpressed CGRP (suggesting a sensory nerve phenotype), in the uterus, CLCA4 and CGRP were expressed in separate nerve fibers. The full identity and functional role of CLCA4-immunopositive structures in the uterus remain unclear.
Contractility of the mouse uterus varies considerably across the 4-to 5-day estrous cycle, with particular motor patterns predominating at each stage. The finding that three pharmacologically distinct inhibitors of Cl À channels reduced contraction frequency at estrus supports a role for a Cl À conductance in the generation of spontaneous uterine contractions. Kit-immunopositive ICLCs were not consistently observed within the nonpregnant mouse uterus, suggesting that spontaneous contractions are either generated by a yetunidentified Kit-negative pacemaker cell type, or are due to an intrinsic property of the uterine myocytes. The distribution of two candidate CaCCs, Ano1 and CLCA4, suggests that these are unlikely to be the molecular candidates for the I Cl-Ca underlying spontaneous contractions of the mouse uterus.
